Riverside purchases herbal extracts manufacturer Euromed for €82M
December 31, 2015
The Riverside Company has acquired Euromed for €82 million from Swedish pharmaceutical company Meda (STO: MEDAA). Euromed, an herbal extracts and natural active substances manufacturer, generates about €40 million in sales and an EBITDA margin of around 20% on an annual basis. European Capital provided financing for the deal; Fidentiis, Uria and Deloitte advised Riverside.